Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |